Dupilumab in combination with other biologic agents is safe and effective for treating various chronic inflammatory conditions.

Biological drugs have improved the lives of many people with severe asthma. However, a new study from Karolinska Institutet ...

Substantial challenges characterise the management of chronic obstructive pulmonary disease (COPD), including a progressively ...

The Lancet on the anti-IL-5 antibody mepolizumab in individuals with allergic asthma, evidence has accumulated that the pathogenetic role of eosinophils is fundamentally different between asthma ...

Patients with asthma and allergic bronchopulmonary aspergillosis experienced improvements with dupilumab, according to data presented at the American Thoracic Society International Conference.Quality ...

Biologics, including medications like mepolizumab and dupilumab, are widely prescribed for patients with severe asthma and ...

Dupilumab use in asthma linked to higher lymphoma risk, especially T/NK cell types, though overall mortality was lower, new ...

A new study has found that while biologic drugs have helped many people with severe asthma manage their symptoms, they may not completely get rid of the immune cells that ...

Any conflicts of interest are reported in the published paper. "High-Dimensional Analysis of Type 2 Lymphocyte Dynamics During Mepolizumab or Dupilumab Treatment in Severe Asthma", Lorenz Wirth, ...

The Food and Drug Administration has approved Dupixent (dupilumab) for the treatment of adult patients with bullous pemphigoid.

New Delhi, June 26 (IANS): While biological drugs or biologics have improved the lives of many people with severe asthma, a new study shows that some immune cells with high inflammatory potential are ...